Position in BMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,205,861
-$4,346,580 QoQ
Shares Held
55,638
-55.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#676
of 2,506 holders
Holding Since
Sep 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Derivatives in BMY
reported options exposure · as of Dec 31, 2020CallValue
$24,812,000
CallShares
400,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Atom Investors LP holds $8,244,252 across 3 Drug Manufacturers - General names. BMY ranks #2 (38.9% of the industry book) .
All Filings in BMY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,205,861 | 55,638 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $7,552,441 | 124,525 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $4,578,055 | 101,509 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,417,124 | 52,217 | Shares | Sole | 2025-08-14 | |
| 2024-06-30 | $1,760,872 | 42,400 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $301,030 | 5,551 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,227,386 | 23,921 | Shares | Sole | 2024-02-14 | |
| 2020-12-31 | $24,812,000 | 400,000 | Call | Sole | 2021-02-16 | |
| 2020-09-30 | $324,963 | 5,390 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||